News & Events

my-photo-2581_web
17.02.2015

DYCONEX expands its center of competence for product reliability

DYCONEX AG, an MST company and a world leading supplier of highly complex PCB solutions, opened up new reliability testing laboratories in December 2014 and in doing so further expanded this center of competence.
The new labs unify all the processes needed for the precise monitoring of product reliability.

MST at MD&M East New York 2015

mdm_east_108px

Medical Design & Manufacturing
June 9 - 11, 2015
Jacob K. Javits Convention Center, New York, NY, USA
Hall 3, Booth# 2207

DYCONEX at PCB West 2015

pcb_west_108px

PCB Industry
September 15 - 17, 2015
Convention Center, Santa Clara, CA, USA


DYCONEX LIQUID CRYSTAL POLYMER (LCP) SUBSTRATE PROVES CYTOTOXICITY CONFORMITY ACCORDING TO ISO 10993-5

Cytotoxicity, a standardized test for materials used in medical devices, is used to determine if significant quantities of harmful extractable substances are present and how these may negatively affect cellular components. Harlan Cytotest Cell Research GmbH recently performed a cytotoxicity test on an LCP product manufactured by DYCONEX and certified in an official declaration the non-cytotoxicity of the product and it's suitability for in-vitro application.

Due to its biocompatibility, hermeticity properties, chemical inertness and advantageous electromechanical properties, LCP circuit boards are especially well-suited for biomedical and temporary implantable applications.